Prostaglandin catabolizing enzymes

被引:258
作者
Tai, HH [1 ]
Ensor, CM [1 ]
Tong, M [1 ]
Zhou, HP [1 ]
Yan, FX [1 ]
机构
[1] Univ Kentucky, Div Pharmaceut Sci, Coll Pharm, Lexington, KY 40536 USA
来源
PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2002年 / 68-9卷
关键词
prostaglandins; thromboxane; short-chain dehydrogenases; aldo-keto; reductases;
D O I
10.1016/S0090-6980(02)00050-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The primary catabolic pathway of prostaglandins and related eicosanoids is initiated by the oxidation of 15(S)-hydroxyl group catalyzed by NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) followed by the reduction of A 13 double bond catalyzed by NADPH/NADH dependent Delta(13)-15-ketoprostaglandin reductase (13-PGR). 13-PGR was also found to exhibit NADP(+)-dependent leukotriene B-4 12-hydroxydehydrogenase (12-LTB4DH) activity. These enzymes are considered to be the key enzymes responsible for biological inactivation of prostaglandins and related eicosanoids. A separate catabolic pathway of thromboxane involves the oxidation of thromboxane B-2 (TXB2) at C-I I catalyzed by NAD(+)-dependent I-hydroxythromboxane B2 dehydrogenase (11-TXB2DH). The product of this reaction, I I-dehydro-TXB2, has been considered to be a more reliable quantitative index of thromboxane formation in the circulation. Recent biochemical and molecular biological studies have revealed interesting catalytic properties, structure, and activity relationship, and regulation of gene expression of these three enzymes. Future investigation may shed more light on the roles of these enzymes in health and diseases. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 73 条
[1]   IDENTIFICATION OF 12-KETO-5,8,10-HEPTADECATRIENOIC ACID AS AN ARACHIDONIC-ACID METABOLITE PRODUCED BY HUMAN HL-60 LEUKEMIA-CELLS [J].
AGINS, AP ;
THOMAS, MJ ;
EDMONDS, CG ;
MCCLOSKEY, JA .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (11) :1799-1805
[2]   BIOLOGICAL ACTIVITIES OF 3 METABOLITES OF PROSTAGLANDIN E1 [J].
ANGGARD, E .
ACTA PHYSIOLOGICA SCANDINAVICA, 1966, 66 (04) :509-&
[3]   DISTRIBUTION OF 15-HYDROXY PROSTAGLANDIN DEHYDROGENASE AND PROSTAGLANDIN DELTA-13 REDUCTASE IN TISSUES OF SWINE [J].
ANGGARD, E ;
LARSSON, C ;
SAMUELSSON, B .
ACTA PHYSIOLOGICA SCANDINAVICA, 1971, 81 (03) :396-+
[4]   The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity [J].
Barski, OA ;
Gabbay, KH ;
Bohren, KM .
BIOCHEMISTRY, 1996, 35 (45) :14276-14280
[5]   HIGHLY POTENT INHIBITION OF PROSTAGLANDIN 15-HYDROXYDEHYDROGENASE INVITRO AND OF PROSTAGLANDIN INACTIVATION IN PERFUSED LUNG BY THE NEW AZOBENZENE ANALOG, PH-CL-28A [J].
BERRY, CN ;
HOULT, JRS ;
PHILLIPS, JA ;
MCCARTHY, TM ;
AGBACK, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (09) :622-628
[6]  
BOHREN KM, 1992, J BIOL CHEM, V267, P20965
[7]   Cloning of guinea pig cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase complementary deoxyribonucleic acids: Steroid-modulated gene expression correlates to prostaglandin F-2 alpha secretion in cultured endometrial cells [J].
Bracken, KE ;
Elger, W ;
Jantke, I ;
Nanninga, A ;
Gellersen, B .
ENDOCRINOLOGY, 1997, 138 (01) :237-247
[8]   11-DEHYDROTHROMBOXANE-B2 - A QUANTITATIVE INDEX OF THROMBOXANE-A2 FORMATION IN THE HUMAN CIRCULATION [J].
CATELLA, F ;
HEALY, D ;
LAWSON, JA ;
FITZGERALD, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :5861-5865
[9]  
Celis JE, 1996, CANCER RES, V56, P4782
[10]   PROSTAGLANDIN 9-KETOREDUCTASE AND TYPE-II 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE FROM SWINE KIDNEY ARE ALTERNATE ACTIVITIES OF A SINGLE ENZYME PROTEIN [J].
CHANG, DGB ;
SUN, M ;
TAI, HH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 99 (02) :745-751